2. News
  3. Press Release

Press Release

Search
2020.09.25
U.S. FDA Approves Clinical Trials for Repositioning of Dong-A ST’s Diabetes Drug 'Suganon' as a CAVD treatment
Businesskorea
rednvia

REDNVIA Co., Ltd.
11F, 88, Olympic-ro 43-gil, Songpa-gu, Seoul,
[05505] Republic of Korea
Tel:+82-2-2039-1217     Fax: +82-70-8280-1218     
For Investor relations: rednvia_contact@rednvia.com
Copyright © REDNVIA Co., Ltd. All right reserved.

top